Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?HASHIMOTO, Kenji; UENO, Hideki; IKEDA, Masafumi et al.Oncology. 2009, Vol 77, Num 3-4, pp 217-223, issn 0030-2414, 7 p.Article

Altered Gene Expression in Rat Colonic Adenocarcinomas Induced in an Azoxymethane plus 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]-Pyridine Initiation-Promotion ModelDOI, Kenichiro; HAGIHARA, Atsushi; MIN WEI et al.Oncology. 2007, Vol 73, Num 3-4, pp 252-260, issn 0030-2414, 9 p.Article

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 CasesSUZUKI, Eiichiro; FURUSE, Junji; KOJIMA, Yasushi et al.Oncology. 2010, Vol 79, Num 1-2, pp 39-45, issn 0030-2414, 7 p.Article

A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolizationTANAKA, Tsutomu; IKEDA, Masafumi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 683-688, issn 0344-5704, 6 p.Article